Author: hivecanada
The Buzz, Issue #10 is now out! This issue features randomized studies for monoclonal antibodies in CSU, a look at how Canadian parents view oral food challenge, Canadians use of topical cannabinoids, and a scoping review for identifying drug culprits for adverse cutaneous drug reactions.
The Buzz Issue #10, December 2021 edition, will be sent to all HIVE members by email on Mon, December 27th, and can be accessed online here.
To view all issues of The Buzz, go to thehivecommunity.org/the-buzz
The Buzz, Issue #9 is now out! This issue features adverse events following vaccination, a case series on complement measurements in hereditary angioedema, a retrospective analysis of psoriasiform lesion in children taking dupilumab, and two systematic reviews, one in chronic urticaria and the other in food allergy.
The Buzz Issue #9, November 2021 edition, will be sent to all HIVE members by email on Thurs, November 25th, and can be accessed online here. This edition covers:
- Vaccine pharmacovigilance and management of immune and non-immune adverse vaccine events
- C1-inhibitor and C4 as diagnostic markers in hereditary angioedema
- Psoriasiform eruptions in children taking dupilumab for atopic dermatitis
- Systematic review of methotrexate in chronic urticaria
- Protocol for a systemic review of food allergy diagnostic test accuracy
To view all issues of The Buzz, go to thehivecommunity.org/the-buzz
Protected: Updates from EADV 2021: Drs. Charles Lynde and Connie Zhang review results from a dedicated Phase 2b study on adolescents with CSU (Video 4 min)
The Buzz, Issue #8 is now out! This issue features new international urticaria guidelines, a trial of convalescent plasma in COVID-19, and new publications on peanut immunotherapy, food allergy desensitization, and combination treatment for allergic rhinitis.
The Buzz Issue #8, October 2021 edition, will be sent to all HIVE members by email on Tuesday, October 26th, and can be accessed online here. This edition covers:
- Updated guidelines for chronic urticaria
- The CONCOR-1 study of convalescent plasma for COVID-19 treatment
- Post-hoc analysis of allergic reaction severity from a peanut immunotherapy study
- Dupilumab and subcutaneous immunotherapy for allergic rhinitis
- Future strategies in food allergy desensitization
To view all issues of The Buzz, go to thehivecommunity.org/the-buzz
Protected: Updates from EADV 2021: Drs. Charles Lynde and Sophia Xu review anti-histamine failure in chronic urticaria (Video 6 min)
Protected: Watch the recorded webinar: Dr. Moshe Ben-Shoshan introduces a unique patient education video on chronic spontaneous urticaria
The Buzz, Issue #7 is now out! In this issue we feature five new publications with high clinical relevance for Canadian allergists.
The Buzz Issue #7, September 2021 edition, will be sent to all HIVE members by email on Tuesday, September 14th, and can be accessed online here. This edition covers:
- Challenges and success in implementing the findings from LEAP
- Using graded oral challenge to confirm hypersensitivity to amoxicillin
- Clinical and demographics characteristics of HAE patients in Canada
- Comorbid autoimmune diseases in Type IIb autoimmune CSU
- Review of urticarial vasculitis
To view all issues of The Buzz, go to thehivecommunity.org/the-buzz
Protected: Special Invitation to HIVE Members: Virtual-Live Presentation of a Unique Five-minute Patient Education Video on Chronic Spontaneous Urticaria
The Buzz, Issue #6 is now available, featuring five new publications with high clinical relevance for Canadian allergists.
The Buzz Issue #6, August edition, will be sent to all HIVE members by email on Monday, July 26, and can be accessed online here. This edition covers:
- Seroconversion following vaccination for patients on anti-CD20 therapy
- Association between meconium metabolome and atopy in Canadian infants
- Context for a network meta-analysis of antihistamines in chronic spontaneous urticaria
- Case series and systematic review of omalizumab for idiopathic anaphylaxis
- Review on allergic rhinitis management
To view all issues of The Buzz, go to thehivecommunity.org/the-buzz
The HIVE Community 